Courtagen Life Sciences, Inc. Announced Today The Launch Of Two New Next Generation DNA Sequencing Tests For Neurodevelopmental Disorders, Developmental Delay, Intellectual Disability, And Autism Spectrum Disorders

WOBURN, Mass.--(BUSINESS WIRE)--Courtagen Life Sciences, Inc., an innovative molecular information company, announced today the release of the devSEEK™ Sequence Analysis for Neurodevelopmental Disorders Panel and the devACT™ Clinical Management Panel.

Help employers find you! Check out all the jobs and post your resume.